TABLE 2.

Univariate Cox Regression Analyses for Risk of Biochemical Progression

VariableHRP
Age (y)0.99 (0.92–1.05)0.68
Initial PSA1.00 (0.99–1.01)0.90
Nadir PSA before RP1.32 (0.98–1.77)0.07
ISUP grade at biopsy1.27 (0.65–2.47)0.48
Treatment intervention (ADT + abiraterone vs. ADT + docetaxel)0.98 (0.31–3.10)0.98
Initial clinical T stage
 T20.03*
 T3a0.62 (0.06–6.86)0.69
 T3b4.68 (1.04–21.02)0.04*
SUVmax before treatment1.02 (1.00–1.05)0.02*
SUVmax after treatment1.04 (1.02–1.06)0.00*
SUVmax decline percentage1.00 (0.99–1.00)0.05*
Pathologic N stage (pN1 vs. pN0)1.44 (0.50–4.18)0.50
pCR or minimal residual disease (yes vs. no)0.10 (0.01–0.65)0.02*

  • ISUP = International Society of Urological Pathology.

  • Data in parentheses are 95% CIs.